20180709 logo STipeTx-01.jpg
STipe Therapeutics appoints Dr Richard Sainson as Chief Scientific Officer to Lead Research and Discovery
31 mai 2022 02h00 HE | STipe Therapeutics
AARHUS, Denmark, May 31, 2022 (GLOBE NEWSWIRE) -- STipe Therapeutics (STipe), a company with a novel approach to leverage the STimulator of INterferon Genes (STING) Pathway, a major driver of the...